a reputation for solving drug development challenges
Frontage helps organizations advance their early phase drug development efforts with extensive scientific and analytical services, including bioanalysis, preclinical, and Phase I-IIa studies and CMC product development. Our services and expert guidance span lead candidate identification in drug discovery through late stage clinical development. Biometrics capabilities support Phase I-IV clinical trials. CMC pharmaceutical development offerings range from organic synthesis to product commercialization support.
A deep understanding of drug development, combined with the skills and commitment to solve complex challenges reinforces our ability to deliver reliable data that provides informed decision making. We work with small and large molecules for novel biopharmaceuticals, as well as generic-equivalent and consumer products.
When you choose Frontage, we promise you a collaborative environment and a broad range of services and expertise delivered by skilled professionals. Our entire organization is geared toward flexibility and responsiveness.
Enroll in a Study | FAQ
> Frontage partners with Quanterix in Biomarker Assay Development. Read the Press Release here!
> Frontage is named one of the Northeast's Top 10 Asian-American Businesses of 2015, awarded by USPAACC!
> Frontage expands service offerings to Agrochemical Companies. See the press release HERE!
> Frontage expands Bioanalytical Lab due to increased demand! See the press release HERE!
> Frontage appoints President of Clinical Services. See the press release HERE!
Join Frontage at these upcoming
Trade Shows & Events:
WRIB Bioanalysis Workshop in Orlando, FL
● April 18-22, 2016
AAPS National Biotechnology in Boston, MA
● May 16-18, 2016
ASMS in San Antonio, TX
● June 5-9, 2016
BIO International in San Francisco, CA
● June 6-9, 2016
DIA Annual Meeting in Philadelphia, PA
● June 26-30, 2016
ACS National Meeting in Boston, MA
● August 16-20, 2016